Parenteral Hydration in Patients With Advanced Cancer: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial | Zendy

Éduardo Bruera | Zendy; David Hui | Zendy; Shalini Dalal | Zendy; Isabel TorresVigil | Zendy; Joseph Trumble | Zendy; Joseph Roosth | Zendy; Susan Krauter | Zendy; Carol Strickland | Zendy; Kenneth M. Unger | Zendy; J. Lynn Palmer | Zendy; Julio Allo | Zendy; Susan FrisbeeHume | Zendy; Kenneth Tarleton | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Parenteral Hydration in Patients With Advanced Cancer: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial

Author(s) -

Éduardo Bruera,

David Hui,

Shalini Dalal,

Isabel TorresVigil,

Joseph Trumble,

Joseph Roosth,

Susan Krauter,

Carol Strickland,

Kenneth M. Unger,

J. Lynn Palmer,

Julio Allo,

Susan FrisbeeHume,

Kenneth Tarleton

Publication year - 2012

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2012.44.6518

Subject(s) - medicine , placebo , delirium , randomized controlled trial , quality of life (healthcare) , adverse effect , cancer , physical therapy , intensive care medicine , nursing , alternative medicine , pathology

The vast majority of patients with cancer at the end of life receive parenteral hydration in hospitals and no hydration in hospice, with limited evidence supporting either practice. In this randomized controlled trial, we determined the effect of hydration on symptoms associated with dehydration, quality of life, and survival in patients with advanced cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research